Monday, April 2, 2018

Endo International Places Second Temporary Hold on Compounding ...
7 hours ago - The FDA's guidance, Endo said, states that because “compounded drug products are subject to a lower regulatory standard than FDA-approved drugs, they should only be used by patients whose medical needs cannot be met by an FDA-approved drug.”

No comments: